510(k) Report

510(k) · Cleared

Recalled · Class II · 2016

Medrad Intego Pet Infusion System

K080297510(k) TraditionalCleared Jun 17, 2008134-day reviewClass II21 CFR 880.5725Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medrad, Inc. · FRN Pump, Infusion

Cleared on Jun 17, 2008 as substantially equivalent to K032771 (Medrad, Inc., 2003) and 2 other predicates after a 134-day review. Its family tree reaches back 2 generations to 2002. It has been recalled once.

Decided
Jun 17, 2008
Review
134 days
Class
Class II
Product code
FRN
Recalls
1
Predicates
3

Its longest line of descent runs back 2 generations to K021988 (2002). 4 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2005: 1 other ancestor2003: 1 other ancestorK021988 · Medrad Continuum MR Compatible Infusion System · Medrad, Inc. · 2002 · recalledK032771 · Medrad Continuum MR Infusion System · Medrad, Inc. · 2003 · recalled200020022004200620082010
Other ancestors, by generation 1 generation back: 2 other ancestors K032771 · Medrad Continuum MR Infusion System · Medrad, Inc. · 2003 · recalledK021988 · Medrad Continuum MR Compatible Infusion System · Medrad, Inc. · 2002 · recalled0
  1. Root · 2 generations backK021988 Medrad Continuum MR Compatible Infusion SystemMedrad, Inc. · 2002 · Recalled
  2. 1 generation backK032771 Medrad Continuum MR Infusion SystemMedrad, Inc. · 2003 · Recalled
  3. This deviceK080297 Medrad Intego Pet Infusion SystemMedrad, Inc. · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K021988Medrad Continuum MR Compatible Infusion SystemMedrad, Inc.20021
−1K032771Medrad Continuum MR Infusion SystemMedrad, Inc.20031
0 (this device)K080297Medrad Intego Pet Infusion SystemMedrad, Inc.2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200310
200510
FIG. 1 — Lineage of K080297, 2002–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FRN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRN device

  1. #1 K253703 RemunityPRO+ Pump for Remodulin®…score 12.6 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032771Medrad Continuum MR Infusion System
Summary page 1
…MEDRAD Intego T M PET Infusion System PREDICATE DEVICES: · MEDRAD Continuum MR Infusion System (K032771) * Cal/Rad Mark VI/VDC-05 Dose Calibrator, Model 34-1…
Medrad, Inc.20031
*K030066Cal/Rad Mark VI/VDC-505 Dose Calibrator, Model 34-165
Summary page 1
…(K032771) * Cal/Rad Mark VI/VDC-05 Dose Calibrator, Model 34-165 (K030066) * Personnel Protective Shield (Class I exempt) * Radio…
Nuclear Associates2003—
*K050456Medrad Avanta Fluid Management Injection System
Summary page 1
…em (Class II) * MEDRAD Avanta Fluid Management Injection System [Patient Administration Set] (K050456) INTENDED USE: The MEDRAD Intego PET Infusion System is intended to deliver accurate doses of 18F Fluorodeoxyglucose (FDG) radio…
Medrad, Inc.20056
*—Personnel Protective Shield
Named without a submission number
—
*—Radionuclide Rebreather System
Named without a submission number
—

Also cleared against K032771: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 30, 2016Class IIZ-0400-2017Process controlThe Source Administration Sets (SAS) used with the Medrad Intego PET Infusion System do not meet pressure testing specifications in an occlusion situation when the product is more than one year past manufacturing date.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 1 company; a new generation was cleared every 4.7 years on median.
  • 3 of the 4 ancestors have a recall of any class.
  • 3 other devices also cite its predicate K032771.

How does its category compare?

All FRN devices

FRN Pump, Infusion: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · FRN

8in 2025

2007: 122008: 82009: 92010: 32011: 32012: 42013: 62014: 62015: 32016: 32017: 32018: 32019: 22020: 12021: 22022: 62023: 72024: 52025: 82026 (partial year): 2
2007high 12 (2007) · low 1 (2020)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRN

172in 2025

2007: 102 days median2008: 89 days median2009: 66 days median2010: 93 days median2011: 103 days median2012: 217 days median2013: 312 days median2014: 172 days median2015: 232 days median2016: 301 days median2017: 305 days median2018: 267 days median2022: 268 days median2023: 265 days median2024: 103 days median2025: 172 days median
2007high 312 (2013) · low 66 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRN

7in 2025

2007: 152008: 242009: 1022010: 372011: 692012: 42, 2 Class I2013: 22, 3 Class I2014: 4, 3 Class I2015: 52016: 7, 1 Class I2017: 132018: 12019: 18, 1 Class I2020: 16, 5 Class I2021: 3, 2 Class I2022: 22023: 16, 10 Class I2024: 9, 4 Class I2025: 7, 4 Class I2026 (partial year): 11, 2 Class I
2007high 102 (2009) · low 1 (2018)2026

Class I (37 since 2007) Class II/III not classified

Adverse event reports per year · FRN

52,792in 2025

2007: 1,0862008: 8,2612009: 1,9522010: 6,1332011: 41,3672012: 15,4822013: 40,0822014: 94,1802015: 26,7422016: 16,5602017: 12,0602018: 16,5912019: 15,8502020: 94,1862021: 199,3422022: 888,0202023: 165,8382024: 57,7302025: 52,792
2007high 888,020 (2022) · low 1,086 (2007)2025

MAUDE reports naming product code FRN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200712102151,086
2008889248,261
20099661021,952
2010393376,133
201131036941,367
2012421742 (2)15,482
2013631222 (3)40,082
201461724 (3)94,180
20153232526,742
201633017 (1)16,560
201733051312,060
20183267116,591
20192—18 (1)15,850
20201—16 (5)94,186
20212—3 (2)199,342
202262682888,020
2023726516 (10)165,838
202451039 (4)57,730
202581727 (4)52,792
20262—11 (2)—

What is it indicated for?

The MEDRAD Intego PET Infusion System is intended to deliver accurate doses of 18F Fluorodeoxyglucose (FDG) radiopharmaceuticals and commonly used flushing solutions to patients during molecular imaging (nuclear medicine) diagnostic procedures. The MEDRAD Intego PET Infusion System is also intended to provide effective radiation shielding to medical personnel from Fluorine-18 (18F) radiation exposure during nuclear medicine diagnostic procedures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K080297: Medrad Intego Pet Infusion System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K080297

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026